Published in Digestion on January 01, 1982
Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation. Ann Surg (1985) 0.99
Gallstones in Patients with Chronic Liver Diseases. Biomed Res Int (2017) 0.75
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J Biol Chem (1997) 2.47
Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol (1996) 1.85
The treatment of retained biliary stones with monooctanoin: report of 16 patients. Am J Gastroenterol (1984) 1.52
Gene suppression by tristetraprolin and release by the p38 pathway. Am J Physiol Lung Cell Mol Physiol (2001) 1.44
Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation. Mol Med (1996) 1.28
Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol (1989) 1.27
Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants. J Immunol (1990) 1.25
Regulation of TNF expression by multiple mitogen-activated protein kinase pathways. J Immunol (2000) 1.25
Role of spleen in immune response to polyvalent pneumococcal vaccine. Br Med J (Clin Res Ed) (1983) 1.17
Methyl tert-butyl ether fails to dissolve retained radiolucent common bile duct stones. Gastroenterology (1986) 1.14
Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci U S A (1991) 1.13
Bile acid-induced inhibition of the lymphoproliferative response to phytohemagglutinin and pokeweed mitogen: an in vitro study. Gastroenterology (1980) 1.12
Unexpected dilatation of the common bile duct after methyl tertiary butyl ether (MTBE) in rabbits. Possible implications to findings in man. Gut (1989) 1.08
Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice. J Immunol (1997) 1.08
Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J Immunol (2001) 1.03
Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1. Exp Cell Res (2000) 1.00
First pass metabolism of ethanol--a gastrointestinal barrier against the systemic toxicity of ethanol. Life Sci (1985) 1.00
Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery. Clin Exp Immunol (1991) 0.98
Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda. Am J Med Sci (1983) 0.97
Impaired antipneumococcal antibody production in patients without spleens. Br Med J (Clin Res Ed) (1985) 0.96
All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex. Eur J Biochem (1999) 0.91
Coordinate activation of endogenous p38alpha, beta, gamma, and delta by inflammatory stimuli. J Leukoc Biol (2000) 0.90
Pharmacology of cyclosporine (sandimmune). I. Introduction. Pharmacol Rev (1990) 0.89
Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids. Methods Find Exp Clin Pharmacol (1984) 0.88
Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats. Toxicol Appl Pharmacol (1986) 0.88
Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions. J Immunol (1997) 0.87
Acute ethanol administration increases biliary concentrations of total and unconjugated bilirubin in rabbits. Dig Dis Sci (1981) 0.86
Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda. Br J Dermatol (1983) 0.85
S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology (1990) 0.83
Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology (1990) 0.82
Is long-term immunosuppressive treatment necessary to maintain good kidney graft function? Br Med J (1979) 0.82
Lithogenic bile after conjugated estrogen. N Engl J Med (1976) 0.81
Inhibition of lymphocyte function by a naturally occurring nucleoside: 5'-methylthioadenosine (MTA). Int J Immunopharmacol (1985) 0.81
Are pigmented gall stones caused by a "metabolic" liver defect? Br Med J (1980) 0.81
Human alpha beta T-cell receptor CD4-CD8 T-cell clones are predominantly Th0-like. Immunology (1995) 0.80
Appearance of spontaneously Ig secreting B cells in human peripheral blood after surgery. Clin Exp Immunol (1986) 0.80
p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts. Eur Cytokine Netw (1995) 0.80
S-adenosyl-L-methionine protection against alpha-naphthylisothiocyanate-induced cholestasis in the rat. Toxicol Lett (1985) 0.80
Spontaneous and polyclonal Ig secretion by circulating B cells after surgery. Surgery (1988) 0.79
Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism. Gastroenterology (1981) 0.79
Immunologic cross-reactivity of antigen(s) induced by drug treatment in two leukemic sublines. J Immunol (1976) 0.79
Improved methods for the measurement of acetaldehyde concentrations in plasma and red blood cells. Alcohol Clin Exp Res (1986) 0.78
Functional and morphological suppressor T cell deficit in acute GVHD. Clin Exp Immunol (1984) 0.78
Bile secretion and liver microsomal mixed function oxidase system in mice with griseofulvin-induced hepatic protoporphyria. Toxicology (1983) 0.78
Influence of S-adenosyl-L-methionine on irreversible binding of ethynylestradiol to rat liver microsomes, and its implication in bile secretion. Biochem Pharmacol (1979) 0.78
A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis. Methods Find Exp Clin Pharmacol (1990) 0.78
Effect of cicloxilic acid on bile lipid composition in patients with gallstones: a multicenter trial. Digestion (1983) 0.78
Red blood cells: a new major modality for acetaldehyde transport from liver to other tissues. Life Sci (1987) 0.78
Human basophils express interleukin-4 receptors. Blood (1990) 0.78
A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients. Photodermatol (1984) 0.78
Treatment of depression in HIV-infected patients. J Psychiatry Neurosci (1998) 0.77
Effect of cicloxilic acid on bile flow and biliary lipid secretion in humans. Am J Gastroenterol (1984) 0.77
Abnormal serum gamma-glutamyltranspeptidase in alcoholics. Clues to its explanation. Neth J Med (1989) 0.77
S-adenosyl-L-methionine antagonizes ethynylestradiol-induced bile cholesterol supersaturation in humans without modifying the estrogen plasma kinetics. Gastroenterology (1982) 0.77
Effects of iron overload on bile secretion and hepatic porphyrin metabolism in ethinyl estradiol-treated rats. Toxicology (1986) 0.77
Prevention of S-adenosylmethionine of estrogen-induced hepatobiliary toxicity in susceptible women. Am J Gastroenterol (1988) 0.76
Decreased blood levels of ethanol and acetaldehyde by S-adenosyl-L-methionine in humans. Arch Toxicol Suppl (1984) 0.76
Effect of S-adenosyl-L-methionine on ethynylestradiol-induced impairment of bile flow in female rats. Experientia (1977) 0.76
Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice. Infect Immun (1997) 0.76
Detection of enterobacterial lipopolysaccharides and experimental endotoxemia by means of an immunolimulus assay using both serotype-specific and cross-reactive antibodies. J Infect Dis (1993) 0.76
Ceruletide for retained biliary stones. Br Med J (Clin Res Ed) (1986) 0.75